Tohoku University Hospital
Sendai's university hospital and the clinical arm of the Tohoku Medical Megabank, with strengths in breast cancer, gastroenterology and imaging.
Tohoku University Hospital is the leading academic hospital of north-eastern Japan and a designated core hospital for cancer genome medicine. Tohoku University's Institute of Development, Aging and Cancer and the Tohoku Medical Megabank Organization, created after the 2011 earthquake, provide large genomic and cohort resources, and the hospital is known for breast cancer research (including steroid receptor pathology under Hironobu Sasano), gastrointestinal endoscopy and surgery, thoracic surgery and radiological sciences. Its investigators are active in JCOG, the Japan Breast Cancer Research Group and hepatology trials, and the Tohoku region operates one of Japan's newer proton facilities nearby.
- Breast cancer pathology and trials
- Tohoku Medical Megabank cohorts
- Gastroenterology
- Radiological sciences
Pages like this
not linked directly; found by shared links- InstitutionShizuoka Cancer Center
Shares Whole-exome & whole-genome sequencing, Germline (hereditary) testing, Gastric & gastro-oesophageal junction cancer, Colorectal cancer.
- InstitutionNational University Hospital / National University Cancer Institute, Singapore
Shares Whole-exome & whole-genome sequencing, Gastric & gastro-oesophageal junction cancer, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- IdeaStore adult-onset cancer gene results from newborn genomes and disclose at 18
Shares Whole-exome & whole-genome sequencing, Germline (hereditary) testing.
- IdeaOncology teams order germline tests; tele-genetic counsellors handle the results
Shares Germline (hereditary) testing, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionAichi Cancer Center
Shares Gastric & gastro-oesophageal junction cancer, HR-positive / HER2-negative breast cancer, Colorectal cancer, Non-small-cell lung cancer.
- InstitutionKing Hussein Cancer Center
Shares Germline (hereditary) testing, HR-positive / HER2-negative breast cancer, Colorectal cancer, Non-small-cell lung cancer.
- IdeaLook for the resistant sub-population before the first dose
Shares Estrogen receptor (ERα), HR-positive / HER2-negative breast cancer, Colorectal cancer, Non-small-cell lung cancer.
- InstitutionUniversity of Malaya Medical Centre
Shares Germline (hereditary) testing, HR-positive / HER2-negative breast cancer, Colorectal cancer.